Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > OTC Pet Medication Market

OTC Pet Medication Market Share

Report ID: GMI6068
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

OTC Pet Medication Market Share

Some of the major market players operating in the OTC pet medication market are

Zoetis Inc.
Merck & Co., Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Virbac
Vetoquinol
PetIQ, LLC.
Norbrook
Bimeda, Inc.

These players focus on strategic partnerships, new product launch & commercialization for market expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global OTC pet medication industry was valued over USD 8 billion in 2022 and will cross USD 15 billion by 2032, driven by increasing pet ownership, growing awareness among pet owners regarding the importance of preventive healthcare, and rising adoption of pet insurance.

In 2022, the flea and tick control segment accounted for 45.3% market share. Pet owners prioritize the health and comfort of their pets, which along with increasing incidences of parasitic infections in pets is boosting the product demand.

North America OTC pet medication market is expected to reach USD 5.4 billion by 2032, on account of a high rate of pet ownership, and rising demand for over-the-counter drugs to address common health conditions in pets.

Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Virbac, Vetoquinol, PetIQ, LLC., Norbrook, and Bimeda, Inc.